BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 11720066)

  • 1. Selective cyclo-oxygenase-2 inhibitor-induced oliguria: a postoperative complication.
    Smiles J; Walker R
    Intern Med J; 2001 Nov; 31(8):497-8. PubMed ID: 11720066
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclooxygenase 2 selective agents and upper gastrointestinal disease.
    Palmer RH
    JAMA; 2000 Apr; 283(15):1961-2. PubMed ID: 10789662
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyclooxygenase 2 selective agents and upper gastrointestinal disease.
    Fernandez H; Lesser GT
    JAMA; 2000 Apr; 283(15):1961; author reply 1962. PubMed ID: 10789661
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclooxygenase 2 selective inhibitor induced bowel stricture: a case report.
    Mir O; Dhote R; Scavennec R; Ropert S; Christoforov B
    Gut; 2004 Jan; 53(1):154. PubMed ID: 14684594
    [No Abstract]   [Full Text] [Related]  

  • 5. Reporting of 6-month vs 12-month data in a clinical trial of celecoxib.
    Wright JM; Perry TL; Bassett KL; Chambers GK
    JAMA; 2001 Nov; 286(19):2398-400. PubMed ID: 11712925
    [No Abstract]   [Full Text] [Related]  

  • 6. Reporting of 6-month vs 12-month data in a clinical trial of celecoxib.
    Hrachovec JB; Mora M
    JAMA; 2001 Nov; 286(19):2398; author reply 2399-400. PubMed ID: 11712924
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiovascular events and COX-2 inhibitors.
    Fleming M
    JAMA; 2001 Dec; 286(22):2808; author reply 2811-2. PubMed ID: 11735742
    [No Abstract]   [Full Text] [Related]  

  • 8. Celecoxib-induced acute pancreatitis and hepatitis: a case report.
    Carrillo-Jimenez R; Nurnberger M
    Arch Intern Med; 2000 Feb; 160(4):553-4. PubMed ID: 10695699
    [No Abstract]   [Full Text] [Related]  

  • 9. Selective cyclooxygenase-2 inhibitors: a pattern of nephrotoxicity similar to traditional nonsteroidal anti-inflammatory drugs.
    Perazella MA; Tray K
    Am J Med; 2001 Jul; 111(1):64-7. PubMed ID: 11448662
    [No Abstract]   [Full Text] [Related]  

  • 10. Pain management in patients with osteoarthritis.
    Finucane TE
    JAMA; 2003 Jul; 290(1):36; author reply 36. PubMed ID: 12837705
    [No Abstract]   [Full Text] [Related]  

  • 11. Are selective COX 2 inhibitors superior to traditional non steroidal anti-inflammatory drugs?
    Jüni P; Rutjes AW; Dieppe PA
    BMJ; 2002 Jun; 324(7349):1287-8. PubMed ID: 12039807
    [No Abstract]   [Full Text] [Related]  

  • 12. Visual disturbance associated with celecoxib.
    Lund BC; Neiman RF
    Pharmacotherapy; 2001 Jan; 21(1):114-5. PubMed ID: 11191731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The coxibs, selective inhibitors of cyclooxygenase-2.
    Killen JP
    N Engl J Med; 2001 Dec; 345(23):1708; author reply 1709. PubMed ID: 11759656
    [No Abstract]   [Full Text] [Related]  

  • 14. COX-2-Selective NSAIDs: new and improved?
    Lichtenstein DR; Wolfe MM
    JAMA; 2000 Sep; 284(10):1297-9. PubMed ID: 10980759
    [No Abstract]   [Full Text] [Related]  

  • 15. COX-2 inhibitors and Celebrex: safe or suspect?
    Health News; 1999 Jun; 5(7):4. PubMed ID: 10932776
    [No Abstract]   [Full Text] [Related]  

  • 16. Celecoxib in patients with asthma and aspirin intolerance. The Celecoxib in Aspirin-Intolerant Asthma Study Group.
    Dahlén B; Szczeklik A; Murray JJ;
    N Engl J Med; 2001 Jan; 344(2):142. PubMed ID: 11188419
    [No Abstract]   [Full Text] [Related]  

  • 17. Arthritis. Should you be taking a COX-2 inhibitor?
    Harv Health Lett; 2001 Nov; 27(1):1-3. PubMed ID: 11724695
    [No Abstract]   [Full Text] [Related]  

  • 18. Celecoxib versus diclofenac and omeprazole to prevent recurrent ulcer bleeding.
    Lanas A
    N Engl J Med; 2003 Jun; 348(24):2464-6; author reply 2464-6. PubMed ID: 12802035
    [No Abstract]   [Full Text] [Related]  

  • 19. Selective celecoxib-associated anaphylactoid reaction.
    Gagnon R; Julien M; Gold P
    J Allergy Clin Immunol; 2003 Jun; 111(6):1404-5. PubMed ID: 12789245
    [No Abstract]   [Full Text] [Related]  

  • 20. Tolerability of three selective cyclo-oxygenase-2 inhibitors, meloxicam, celecoxib and rofecoxib in NSAID-sensitive patients.
    Senna G; Bilò MB; Antonicelli L; Schiappoli M; Crivellaro MA; Bonadonna P; Dama AR
    Eur Ann Allergy Clin Immunol; 2004 Jun; 36(6):215-8. PubMed ID: 15329003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.